Medtronic: Hugo Robotics and Innovative Procedures Double Revenue Growth

The stock of the medical technology company is currently at a 3-year high. A significant contribution to this was the announcement of the current figures for the second quarter of the fiscal year 2026. After an average revenue growth of only 2.7% over the past four years, revenues after the first half of the year rose by 7.5% compared to the previous year. The robotic-assisted surgical system Hugo is a key driver of the long-term growth opportunities. With the medical robot at its back and the prospect of the fifth consecutive revenue record with...